Show simple item record

dc.contributor.authorPurnomo, Yudi
dc.contributor.authorMakdasari, Juliah
dc.contributor.authorInayah Fatahillah, Faiqoh
dc.date.accessioned2023-01-09T09:20:38Z
dc.date.available2023-01-09T09:20:38Z
dc.date.issued2021-11-21
dc.identifier.citationPurnomo, Yudi, Makdasari, Juliah and Fatahillah, Faiqoh Inayah. "Inhibitory activity of Urena lobata leaf extract on alpha-amylase and alpha-glucosidase: in vitro and in silico approach" Journal of Basic and Clinical Physiology and Pharmacology, vol. 32, no. 4, 2021, pp. 889-894en_US
dc.identifier.urihttps://www.degruyter.com/document/doi/10.1515/jbcpp-2020-0430/pdf
dc.identifier.urihttp://repository.unisma.ac.id/handle/123456789/6188
dc.description[ARCHIVES] Copyright Article From: Journal of Basic and Clinical Physiology and Pharmacology (JBCPP)en_US
dc.description.abstractIn food ingestion, alpha-glucosidase (α-glucosidase) and alpha-amylase (α-amylase) are enzymes that are responsible to convert a carbohydrate into glucose. Inhibition of both enzyme activities can prolong absorption of glucose in intestine and reduce post-prandial increase of blood glucose concentration, thus, it is beneficial for type-2 diabetes treatment. Traditionally, Urena lobata (U. lobata) has been used to manage diabetes, but the scientific proof of this claim remains scarce. Therefore, the objective of this study to examine the anti-diabetic potential of U. lobata leaf extract through inhibition of α-amylase and α-glucosidase.en_US
dc.language.isoen_USen_US
dc.publisherJournal of Basic and Clinical Physiology and Pharmacologyen_US
dc.relation.ispartofseriesJournal of Basic and Clinical Physiology and Pharmacology;vol. 32, no. 4, 2021, pp. 889-894
dc.titleInhibitory activity of Urena lobata leaf extract on alpha-amylase and alpha-glucosidase: in vitro and in silico approachen_US
dc.typeArticleen_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record